Related Experiment Video
Updated: Jul 5, 2025

07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.3K
Development and Usability Evaluation of an Opioid Management App
Sagar Deshpande1, Melissa Gunderson1, Geetanjali Rajamani1
1University of Minnesota, Minneapolis, MN, USA.
Studies in Health Technology and Informatics
|January 25, 2024
Summary
A new patient engagement tool (OPY) helps manage post-surgical opioid use. Early testing shows it's easy to use but needs UI/feature enhancements for better patient engagement.
Area of Science:
- Health Informatics
- Behavioral Economics
- Patient Engagement
Background:
- Post-surgical pain management often involves opioid medications.
- Effective patient engagement is crucial for safe opioid use, weaning, and disposal.
- Novel digital tools can support patient behavior change in healthcare settings.
Purpose of the Study:
- To describe the development of a novel patient engagement tool (OPY) for post-surgical opioid medication management.
- To evaluate the early-stage usability and perceived usefulness of the OPY tool from expert and end-user perspectives.
- To identify areas for improvement in the OPY tool's user interface and features.
Main Methods:
- Development of the OPY tool incorporating principles of behavioral economics.
- Expert-based heuristic analysis to assess the tool's design and functionality.
- User testing with end-users (patients) to gather feedback on usability and subjective usefulness.
Main Results:
- Patients found the OPY tool to be easy to use during initial evaluations.
- Subjective usefulness ratings indicated moderate potential, but also room for improvement.
- Expert heuristic analysis and user feedback highlighted the need for UI and feature enhancements.
Conclusions:
- The novel patient engagement tool (OPY) shows promise for improving post-surgical opioid management.
- Further development, particularly in user interface and features, is necessary based on expert and user feedback.
- Close collaboration between developers and stakeholders is essential for optimizing the tool's effectiveness.
Related Concept Videos
Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300
Opioid Analgesics: Morphine and Other Natural Cogeners
250
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
250
Opioid Receptors: Overview
836
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
836
Drug Administration and Therapy Phases: Overview
468
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
468
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K

